International Society for the Study of Women's Sexual Health

NEWS

Flibanserin recommended for approval by the FDA Advisory Committee Panel

Dear ISSWSH members,
It is with great excitement that I share the announcement that flibanserin, a drug for hypoactive sexual desire disorder (HSDD) developed by Sprout Pharmaceuticals, was recommended for approval by the FDA Advisory Committee Panel on June 4, 2015.

This event opens the door for the first treatment for women suffering from HSDD, but more importantly sends the message that the FDA is now willing to entertain new drug applications from other companies. We are optimistic that this occurrence will instigate more research and eventually other therapeutic options. We also offer deep gratitude to many of our members who played a key role in this decision by voting as members of the FDA Advisory Panel, speaking as presenters on behalf of the sponsor, providing testimony during the Open Public Hearing, and caring for patients who also spoke at the Hearing.  

As a multidisciplinary, scientific organization dedicated to research, clinical practice, and education, we are poised to develop and disseminate clinical practice guidelines regarding screening, diagnosis, and management strategies. Through our robust infrastructure of educational programs, we will ensure appropriate, safe, and selective treatment of HSDD with flibanserin when final approval comes.

Most sincerely,
Sharon J. Parish, MD, IF
ISSWSH President, 2014-2016

Save the Date


ISSWSH Annual Meeting 2017

  February 23-26, 2017  2 days left
  Grand Hyatt Atlanta, Atlanta, GA - USA
Read more...


ISSWSH Fall Course 2017

  November 2-5, 2017  254 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

Latest Tweets

Partners of men w/prostate cancer may report even more distress about diagnosis than patient himself https://t.co/M4jQugBqJr ISSWSH
Stephen Porges will reveal how female sexual function emerges from nuanced nervous system changes with stress & ill… https://t.co/YIcyXMmh3t ISSWSH
The Program for the ISSWSH 2017 Annual Meeting is available! https://t.co/lFkSxJg2La https://t.co/YQepamiiYq ISSWSH

Contact Details

ISSWSH Executive Office
PO Box 1233
Lakeville, MN 55044
USA

Phone: +1 (952) 683 9025
Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.